Pancreatic Cancer Research

ResearcherSeoul National UniversityNo recent work listed

Jung Han Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9134-1761; OpenAlex author ID A5101700033. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer. Co-author DOI 10.7150/jca.50514↗
  2. Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis. Co-author DOI 10.18632/oncotarget.20392↗
  3. Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer. Co-author DOI 10.1007/s00280-013-2265-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hunho Song · 2 shared papers, 2013–2021 · strength 0.14
  2. Boram Han · 2 shared papers, 2013–2021 · strength 0.14
  3. Dae Young Zang · 2 shared papers, 2013–2021 · strength 0.14
  4. Jin Won Kim · 1 shared paper, 2021 · strength 0.11
  5. Byoung Yong Shim · 1 shared paper, 2021 · strength 0.11
  6. Hyun Joo Jang · 1 shared paper, 2017 · strength 0.09
  7. Joo Young Jung · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.